A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)

Harbour Cancer & Wellness ( Site 3300), Auckland

Cliniques universitaires Saint-Luc ( Site 1701), Brussels

Melanoma Institute Australia-Clinical Trials Unit ( Site 3205), Wollstonecraft

Austin Health ( Site 3209), Heidelberg

Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si, Brisbane

Debreceni Egyetem Klinikai Kozpont-Bőrgyógyászati Klinika ( Site 2102), Debrecen

Gallipoli Medical Research Ltd-GMRF CTU ( Site 3206), Greenslopes

Gold Coast University Hospital-Cancer and Blood Disorders Clinical Trial Team ( Site 3207), Gold Coast

Sunshine Coast University Hospital-Medical Oncology ( Site 3212), Birtinya

One Clinical Research ( Site 3211), Nedlands

Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Közpo-Department of Dermatology and Allergol, Szeged

Instituto de Investigaciones Clínicas Mar del Plata ( Site 1213), Mar del Plata

Pécsi Tudományegyetem Klinikai Központ-Bőr-, Nemikórtani és Onkodermatológiai Klinika ( Site 2100), Pécs

UZ Gent-Medical oncology ( Site 1702), Ghent

Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz- Onkoradiologiai Osztaly ( Site 2110), Győr

Laura and Isaac Perlmutter Cancer Center ( Site 1121), New York

Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 1160), Mineola

Vseobecna fakultni nemocnice v Praze-Department of Dermatology ( Site 1800), Prague

Assistance Publique Hôpitaux de Marseille - Hôpital de la Timone ( Site 1903), Marseille

Centro Oncologico de Galicia ( Site 2806), A Coruña

UPMC Hillman Cancer Center ( Site 1107), Pittsburgh

Ospedale San Martino-Oncologia Medica 2 ( Site 2303), Genoa

Istituto Clinico Humanitas-U.O di Oncologia medica ed Ematologia ( Site 2304), Rozzano

Centre Hospitalier Universitaire Dijon Bourgogne - Hôpital François Mitterrand ( Site 1904), Dijon

Inova Schar Cancer Institute ( Site 1108), Fairfax

University of Virginia Health System ( Site 1115), Charlottesville

Universitätsklinikum Schleswig-Holstein-Dermatology ( Site 2012), Lübeck

Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII-UOC Oncologia ( Site 2305), Bergamo

Clinica Universidad de Navarra-Medical Oncology ( Site 2807), Madrid

Hospital Universitario Ramón y Cajal-Medical Oncology ( Site 2801), Madrid

H.R.U Malaga - Hospital General ( Site 2805), Málaga

Winship Cancer Institute, Emory University ( Site 1151), Atlanta

Institut Universitaire du Cancer Toulouse - Oncopole - CHU de TOULOUSE ( Site 1908), Toulouse

CHU de Bordeaux Hop St ANDRE ( Site 1902), Bordeaux

University of Kentucky Chandler Medical Center ( Site 1101), Lexington

Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu-Onco-Dermatology ( Site 1910), Nantes

Klinikum Dortmund Klinikzentrum Mitte ( Site 2008), Dortmund

Universitaetsklinikum Essen-Klinik für Dermatologie, Venerologie und Allergologie ( Site 2005), Essen

Hospital General Universitario de Valencia-oncology service ( Site 2802), Valencia

University of Iowa-Holden Comprehensive Cancer Center ( Site 1118), Iowa City

Azienda Ospedaliero Universitaria Senese ( Site 2302), Siena

University Hospital and UW Health Clinics ( Site 1119), Madison

Universitätsmedizin Johannes Gutenberg Universität Mainz ( Site 2007), Mainz

Avera Cancer Institute- Research ( Site 1161), Sioux Falls

Hopital Claude Huriez - CHU de Lille ( Site 1907), Lille

Washington University School of Medicine-Internal Medicine/Oncology ( Site 1100), St Louis

NCT ( Site 2002), Heidelberg

centre hospitalier lyon sud ( Site 1901), Pierre-Bénite

Ochsner Clinic Foundation ( Site 1113), New Orleans

Instituto Tumori Giovanni Paolo II ( Site 2301), Bari

Universitaetsklinikum Tuebingen-Hautklinik ( Site 2003), Tübingen

Hôpital Saint-Louis ( Site 1906), Paris

Istituto Nazionale Tumori IRCCS Fondazione Pascale-s.c. melanoma, immunoterapia oncologica e terapi, Napoli

klinikum rechts der isar der technischen universität münchen ( Site 2009), München

USC/Norris Comprehensive Cancer Center ( Site 1112), Los Angeles

Hoag Memorial Hospital Presbyterian ( Site 1122), Newport Beach

Stanford Cancer Center ( Site 1109), Palo Alto

Gustave Roussy ( Site 1909), Villejuif

University of California Davis (UC Davis) Comprehensive Cancer Center ( Site 1103), Sacramento

Universitaetsklinikum Wuerzburg-Department of Dermatology ( Site 2001), Würzburg

Providence Portland Medical Center ( Site 1102), Portland

Centrul de Oncologie Sfantul Nectarie-Medical ( Site 2601), Craiova

SC Radiotherapy Center Cluj SRL-Oncologie Medicala ( Site 2602), Florești

Oncologos del Occidente ( Site 1504), Pereira

Sigmedical Services SRL ( Site 2603), Suceava

Fundación Valle del Lili ( Site 1502), Santiago de Cali

Emek Medical Center ( Site 2203), Afula

James Lind Centro de Investigacion del Cancer ( Site 1411), Temuco

CIDO SpA-Oncology ( Site 1405), Temuco

Rabin Medical Center ( Site 2202), Petah Tikva

Sheba Medical Center ( Site 2200), Ramat Gan

FALP-UIDO ( Site 1401), Santiago

Clínica Alemana de Santiago-Gynecology and Obstetrics ( Site 1410), Santiago

Hadassah Medical Center ( Site 2201), Jerusalem

ANIMI - Unidade de Tratamento Oncologico ( Site 1312), Lages

Massachusetts General Hospital ( Site 1162), Boston

Dana-Farber Cancer Institute ( Site 1130), Boston

John Theurer Cancer Center at Hackensack University Medical Center ( Site 1125), Hackensack

Atlantic Health System Morristown Medical Center ( Site 1136), Morristown

Fundacion Estudios Clinicos-Oncology ( Site 1205), Rosario

Sanatorio Finochietto ( Site 1202), Buenos Aires

Investigaciones Clinicas Moleculares (ICM) ( Site 1212), CABA

Hospital Italiano de Córdoba ( Site 1204), Córdoba

Clinica Amo - Rio Vermelho-INSTITUTO ETICA ( Site 1315), Salvador

Hospital de Cancer de Londrina-Clinical Research Unit ( Site 1316), Londrina

Associação Hospitalar Beneficente São Vicente de Paulo-Instituto do Câncer ( Site 1309), Passo Fundo

Hospital Nossa Senhora da Conceição-Centro Integrado de Pesquisa em Oncologia ( Site 1300), Porto Alegre

Fundação Faculdade Regional de Medicina de São José do Rio Preto-Centro Integrado de Pesquisa ( Site, São José do Rio Preto

IPITEC ( Site 1313), São Paulo

Jewish General Hospital ( Site 1009), Montreal

Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Univer, Sherbrooke

Fundacion Colombiana de Cancerología Clinica Vida ( Site 1501), Medellín

Oslo universitetssykehus, Radiumhospitalet ( Site 2400), Oslo

Centrum Medyczne HCP ( Site 2505), Poznan

Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 2501), Bydgoszcz

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warsaw

Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 2506), Gdansk

Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakl-Klinika Onkologii Klinicznej, Dzial Ch, Kielce

Spitalul Universitar de Urgență Elias ( Site 2600), Bucharest

Hospital Germans Trias i Pujol-Instituto Catalán de Oncología de Badalona ( Site 2804), Badalona

HOSPITAL CLÍNIC DE BARCELONA-ICHMO- Clinic Institut of Haematological and Oncological diseases ( Sit, Barcelona

Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 2803), Barcelona

Addenbrooke's Hospital-Cambridge Cancer Trials Centre ( Site 3103), Cambridge

Derriford Hospital-Oncology ( Site 3104), Plymouth

Castle Hill Hospital ( Site 3102), Cottingham

Singleton Hospital-South West Wales Cancer Institute ( Site 3100), Swansea